The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole
Abstract Background Fluconazole (FLC) is a widely used antifungal agent; however, Candida albicans is increasingly developing resistance to it. Given the limited range of available antifungal drugs, there is an immediate requirement for the development of novel approaches to improve FLC efficacy aga...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2026-01-01
|
| Reeks: | BMC Microbiology |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12866-025-04701-1 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|